"We are an Integrated Research Organization [IRO] dedicated to optimizing the clinical research experience by delivering a comprehensive research program into our physician's practices. We make clinical research more manageable with our dedicated team of research professionals who match clinical trials to our physicians' areas of interest, assist with patient recruitment and study visits while filing all regulatory requirements."

During the past decade, Circuit Clinical conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Circuit Clinical" #1 sponsor was "Celgene" with 3 trials, followed by "GTx" with 3 trials sponsored, "Astellas Pharma Global Development, Inc." with 2 trials sponsored, "American Regent, Inc." with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Circuit Clinical" #1 collaborator was "COPD Foundation" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "High Plains Research Network" with 1 trials as a collaborator and "L.A. Net Community Health Resource Network" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Circuit Clinical" are "Crohn Disease" (3 trials), "Stress Urinary Incontinence" (3 trials), "Hot Flashes" (2 trials), "Atrial Fibrillation" (1 trials) and "Chronic Obstructive Pulmonary Disease (COPD)" (1 trials). Many other conditions were trialed in "Circuit Clinical" in a lesser frequency.

Most popular intervention types in "Circuit Clinical" are "Drug" (11 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "GTx-024" (2 trials), "placebo" (2 trials) and "Active treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Circuit Clinical" are 7 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Circuit Clinical". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Circuit Clinical, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Circuit Clinical, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".